captured official filings
Medinotec Inc.
Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.
captured official filings
captured official filings
captured official filing
One evidence index instead of a manual filing hunt.
It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.
What teams can pay to automate next.
Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.
Public registration text delta
Comparing S-1/A filed 2022-11-02 with S-1/A filed 2022-11-18.
Tracked-term count changes
Counts are navigation signals, not conclusions. Open both official filings to determine materiality.
- control27 → 31+4
- offering23 → 22-1
Candidate disclosure excerpts
Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.
- Subject to Completion, dated November 18, 2022 PROSPECTUS MEDINOTEC INC. 1,733,750 Shares of Common Stock This prospectus relates to the resale by the Selling Shareholders of up to 1,733,750 shares of our Common Stock, par value $0.001 per share (the “Common Stock”).
- Due to the entities being under the common control of one beneficial owner, the CEO Gregory Vizirgianakis at this stage, a common control transaction was triggered for which the comparative financial information has been adjusted.
- Medinotec Capital Proprietary Limited and DISA Medinotec Proprietary Limited as a result of common control in March with comparative figures for the three and six months ended August 31, 2022 and 2021.
- Subject to Completion, dated November 2, 2022 PROSPECTUS MEDINOTEC INC. 1,733,750 Shares of Common Stock This prospectus relates to the resale by the Selling Shareholders of up to 1,733,750 shares of our Common Stock, par value $0.001 per share (the “Common Stock”).
- At the date of finalization of the decision the shareholding of Medinotec Inc Group and DISA Medinotec Proprietary Limited was effectively the same and therefore a common control transaction was established for which the prior year figures of this set of financials were restarted to show the acquisition with an effective date of
- It also details how the common control transaction arose accordance with ASC 805-50-45-5.
Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.
Save a project-ready issuer record.
US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.
- Source-linked filing chronology and registration path
- Machine-detected amendment and tracked-term change view
- Official-source index for project-file archiving and downloadable CSV export
Secure checkout by PayPal.
Save this source-linked record
Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.
Captured filing chronology
- 10-QReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- DEF 14AGovernanceOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 3OwnershipOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 8-KReporting & material eventsOpen SEC filing →
- 10-QReporting & material eventsOpen SEC filing →
- EFFECTRegistration & offeringOpen SEC filing →
- S-1/ARegistration & offeringOpen SEC filing →
- S-1/ARegistration & offeringOpen SEC filing →
- S-1/ARegistration & offeringOpen SEC filing →
- S-1/ARegistration & offeringOpen SEC filing →
- S-1/ARegistration & offeringOpen SEC filing →
- S-1Registration & offeringOpen SEC filing →
Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.